DE3266460D1 - Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation - Google Patents

Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation

Info

Publication number
DE3266460D1
DE3266460D1 DE8282400285T DE3266460T DE3266460D1 DE 3266460 D1 DE3266460 D1 DE 3266460D1 DE 8282400285 T DE8282400285 T DE 8282400285T DE 3266460 T DE3266460 T DE 3266460T DE 3266460 D1 DE3266460 D1 DE 3266460D1
Authority
DE
Germany
Prior art keywords
carbon atoms
alkyl
dodecahydro
inden
benz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282400285T
Other languages
German (de)
English (en)
Inventor
Marie-Madeleine Bouton
Jean Jacques
Andre Pierdet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of DE3266460D1 publication Critical patent/DE3266460D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
    • C07C49/513—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
DE8282400285T 1981-02-23 1982-02-18 Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation Expired DE3266460D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8103520A FR2500441A1 (fr) 1981-02-23 1981-02-23 Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation

Publications (1)

Publication Number Publication Date
DE3266460D1 true DE3266460D1 (en) 1985-10-31

Family

ID=9255514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282400285T Expired DE3266460D1 (en) 1981-02-23 1982-02-18 Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation

Country Status (11)

Country Link
US (5) US4466971A (enExample)
EP (1) EP0059146B1 (enExample)
JP (2) JPS57156430A (enExample)
AT (1) ATE15761T1 (enExample)
AU (1) AU547375B2 (enExample)
CA (1) CA1195982A (enExample)
DE (1) DE3266460D1 (enExample)
DK (1) DK167113B1 (enExample)
FR (1) FR2500441A1 (enExample)
IE (1) IE52327B1 (enExample)
ZA (1) ZA821001B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2500441A1 (fr) * 1981-02-23 1982-08-27 Roussel Uclaf Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation
TW224048B (enExample) * 1992-03-30 1994-05-21 Hoechst Roussel Pharma
AU7558900A (en) * 1999-10-14 2001-04-23 Kaken Pharmaceutical Co., Ltd. Tetrahydroquinoline derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1359675A (fr) * 1963-01-14 1964-04-30 Roussel Uclaf Nouveaux composés tricycliques et procédé de préparation
US3499912A (en) * 1963-11-06 1970-03-10 Hoffmann La Roche Process for the preparation of 5-oxo-11alpha-hydroxy - 3,5 - seco-a-nor-pregnan-3-oic acid - 3,11 lactones and derivatives thereof
US3412107A (en) * 1964-09-29 1968-11-19 Hoffmann La Roche 11-hydroxy-5-oxo-3, 5-seco-a-nor-androstan-3-oic acid 3, 11-lactones
US3956316A (en) * 1964-09-29 1976-05-11 Hoffmann-La Roche Inc. 11-Substituted-desA-pregnanes and derivatives thereof
CH558343A (de) * 1965-03-25 1975-01-31 Hoffmann La Roche Verfahren zur herstellung von 9(beta),10(alpha)-steroiden.
US3574688A (en) * 1966-03-22 1971-04-13 Roussel Uclaf Unsaturated 2-oxa steroid derivatives and process for their preparation
US3496199A (en) * 1968-06-17 1970-02-17 Hoffmann La Roche Process for the preparation of 9beta,10alpha-steroids
US3984473A (en) * 1968-10-04 1976-10-05 Hoffmann-La Roche Inc. Stereospecific total steroidal synthesis via substituted C/D-trans indanones
US3984474A (en) * 1975-05-30 1976-10-05 E. R. Squibb & Sons, Inc. 4,5-Secoandrostanes
JPS5538316A (en) * 1978-09-08 1980-03-17 Takeda Chem Ind Ltd Intermediate for synthesis of steroid and its preparation
CA1195997A (en) * 1979-02-23 1985-10-29 Andor Furst Dea-steroids
FR2500441A1 (fr) * 1981-02-23 1982-08-27 Roussel Uclaf Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation

Also Published As

Publication number Publication date
CA1195982A (fr) 1985-10-29
US4849454A (en) 1989-07-18
IE52327B1 (en) 1987-09-16
JPH0420893B2 (enExample) 1992-04-07
FR2500441B1 (enExample) 1984-10-19
AU547375B2 (en) 1985-10-17
JPS57156430A (en) 1982-09-27
JPH0466855B2 (enExample) 1992-10-26
US4927975A (en) 1990-05-22
FR2500441A1 (fr) 1982-08-27
DK167113B1 (da) 1993-08-30
US5158981A (en) 1992-10-27
EP0059146B1 (fr) 1985-09-25
US4466971A (en) 1984-08-21
AU8069982A (en) 1982-09-02
ZA821001B (en) 1983-01-26
EP0059146A1 (fr) 1982-09-01
JPH02243646A (ja) 1990-09-27
US4607054A (en) 1986-08-19
DK75282A (da) 1982-08-24
IE820379L (en) 1982-08-23
ATE15761T1 (de) 1985-10-15

Similar Documents

Publication Publication Date Title
ES8502129A1 (es) Un procedimiento para la preparacion de compuestos de acidos biliares
PT73601B (en) Process for the preparation of piperidilydene derivatives having pharmaceutical properties
AU547375B2 (en) 3-hydroxy dodecahydro benz(e) indene-7-one anti-androgenic use
DE3260465D1 (en) Biphenyl alkyl carboxylated derivatives, process for their preparation and their use as medicines
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
FR2401934A1 (fr) Nouveau procede de preparation d'oximes en 3 de derives steroides
DE3273108D1 (en) 17-alpha-alkyl-17-beta-hydroxy-1-alpha-methyl-4-androsten-3-ones, process for their preparation and pharmaceutical compositions containing them
ES403871A1 (es) Procedimiento para preparar compuestos analogos de lincomi-cina.
DE3662693D1 (en) 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them
EP0128839A3 (en) Labelled steroids, process for their preparation and intermediates, their use in the localization of the glucocorticoid receptors and in the dosage of the number of binding sites
PT74343A (fr) Nouveau procede de preparation de 17 alpha-hydroxy 17 beta- -hydroxyacetyl steroides
DE3371787D1 (en) 17-alpha-pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
HUT34995A (en) Process for producing 7-alpha-substituted-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone derivatives and pharmaceutical compositions containing them as active agents
ES469513A1 (es) Procedimiento para preparar nuevos derivados de pregn-4-eno.
DE3378317D1 (en) Process for the preparation of 17-alpha-bromoethynyl and 17-alpha-iodoethynyl-17-beta-hydroxy steroids, and 17-alpha-bromoethynyl and 17-alpha-iodoethynyl-17-beta-hydroxy steroids
ES8501775A1 (es) Procedimiento para preparar productos estratrienicos marcados con yodo 125 o 131
GB998355A (en) Phenylalanine derivatives
DE2963019D1 (en) Novel 3-beta-amino-2-beta-hydroxy steroids of the androstane, oestrane and pregnane series, processes for their preparation and pharmaceutical compositions
CH609668A5 (en) Process for the preparation of acetic acid derivatives
GB1005639A (en) 2(3)-unsaturated 3-enol ethers of 2-formyl-3-oxo-5ª‡-steroids and process for the preparation thereof
ZA828641B (en) Tridigitoxosides, processes for their preparation and pharmaceutical compositions thereof
JPS5479247A (en) Para-substituted phenylacetic acid derivative and its preparation
GB1117456A (en) 1ªß-methyl-2,3ª‡-methylene steroids and a process for their manufacture
DK92283D0 (da) 11beta-chlorsteroider, fremgangsmader til fremstilling heraf og farmaceutiske praeparater med indhold heraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR